Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Investigation

• Publication date

  2000-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/jci8195PMID 10727451PMCID PMC377461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity

  2016cited by this paper
• Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

  1999cited by this paper
• Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice.

  1999cited by this paper
• IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

  1999cited by this paper
• Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures.

  1999cited by this paper
• Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion.

  1999influential reference
• Cloning of the murine beta5 integrin subunit promoter. Identification of a novel sequence mediating granulocyte-macrophage colony-stimulating factor-dependent repression of beta5 integrin gene transcription.

  1999cited by this paper
• Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.

  1998cited by this paper
• Suppression of Interleukin‐11–mediated bone resorption by cyclooxygenases inhibitors

  1998cited by this paper
• Prostaglandin E2 regulates both interleukin-2 and granulocyte-macrophage colony-stimulating factor gene expression in bovine lymphocytes.

  1998cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone.

  1998cited by this paper
• Control of osteoclast differentiation.

  1998cited by this paper
• Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells.

  1998cited by this paper
• Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.

  1998cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.

  1998cited by this paper
• Hormonal regulation of osteoclast function.

  1998cited by this paper
• Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures.

  1998cited by this paper
• TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*

  1997influential reference
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

  1997cited by this paper
• Differential Allosteric Regulation of Prostaglandin H Synthase 1 and 2 by Arachidonic Acid*

  1997cited by this paper
• Differential Effects of Nonsteroidal Anti‐Inflammatory Drugs on Constitutive and Inducible Prostaglandin G/H Synthase in Cultured Bone Cells

  1997cited by this paper
• Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival.

  1997cited by this paper
• Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

  1997cited by this paper
• Prostaglandin Synthase-1 and Prostaglandin Synthase-2 Are Coupled to Distinct Phospholipases for the Generation of Prostaglandin D2 in Activated Mast Cells*

  1997cited by this paper
• Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.

  1997cited by this paper
• Prostaglandin E2 mediates parathyroid hormone induced osteoclast formation by cyclic AMP independent mechanism.

  1997cited by this paper
• Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast Formation

  1997cited by this paper
• Prostaglandin E2 stimulates osteoclast‐like cell formation and bone‐resorbing activity via osteoblasts: Role of cAMP‐dependent protein kinase

  1996cited by this paper
• Interleukin‐4 inhibits prostaglandin G/H synthase‐2 and cytosolic phospholipase A2 induction in neonatal mouse parietal bone cultures

  1996influential reference
• Transcellular Prostaglandin Production following Mast Cell Activation Is Mediated by Proximal Secretory Phospholipase A and Distal Prostaglandin Synthase 1 (*)

  1996cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Involvement of prostaglandin endoperoxide H synthase‐2 in osteoclast‐like cell formation induced by interleukin‐1β

  1996influential reference
• Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.

  1996cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Prostanoid Receptors of Murine NIH 3T3 and RAW 264.7 Cells

  1996cited by this paper
• Involvement of prostaglandin endoperoxide H synthase-2 in osteoclast-like cell formation induced by interleukin-1 beta.

  1996cited by this paper
• Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II

  1995cited by this paper
• Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

  1995cited by this paper
• Parathyroid hormone increases the number of tartrate-resistant acid phosphatase-positive cells through prostaglandin E2 synthesis in adherent cell culture of neonatal rat bones.

  1995cited by this paper
• Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

  1995cited by this paper
• Granulocyte-macrophage colony stimulating factor suppresses lipopolysaccharide-induced osteoclast-like cell formation in mouse bone marrow cultures.

  1994cited by this paper
• Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

  1994cited by this paper
• Phorbol myristate acetate stimulates osteoclast formation in 1α, 25‐dihydroxyvitamin D3‐primed mouse embryonic calvarial cells by a Prostaglandin‐dependent mechanism

  1994cited by this paper
• Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures.

  1994cited by this paper
• Interleukin-11: a new cytokine critical for osteoclast development.

  1994cited by this paper
• Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol, and prostaglandin E2 in cultured neonatal mouse calvariae.

  1994cited by this paper
• Effects of macrophage colony stimulating factor and granulocyte‐macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells

  1993cited by this paper
• The role of recombinant human M-CSF, IL-3, GM-CSF and calcitriol in clonal development of osteoclast precursors in primate bone marrow.

  1993cited by this paper
• Prostaglandin e2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells

  1992cited by this paper
• Effect of prostaglandins E1, E2, and F2α on osteoclast formation in mouse bone marrow cultures

  1991cited by this paper
• Role of colony‐stimulating factors in osteoclast development

  1991cited by this paper
• TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

  1991cited by this paper
• Effect of 1,25‐dihydroxyvitamin D3 on prostaglandin E2 production in cultured mouse parietal bones

  1991cited by this paper
• Role of prostaglandins in interleukin‐1‐induced bone resorption in mice in vitro

  1991influential reference
• Effect of prostaglandins E1, E2, and F2 alpha on osteoclast formation in mouse bone marrow cultures.

  1991cited by this paper
• Effects of interleukin 3 and of granulocyte‐macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue

  1990cited by this paper
• Parathyroid hormone and lipopolysaccharide induce murine osteoblast-like cells to secrete a cytokine indistinguishable from granulocyte-macrophage colony-stimulating factor.

  1989cited by this paper
• Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism.

  1987cited by this paper
• Stimulation of prostaglandin E2 and bone resorption by recombinant human interleukin 1 alpha in fetal mouse bones.

  1986cited by this paper
• Human transforming growth factor-alpha stimulates bone resorption in vitro.

  1985cited by this paper
• Effects of parathyroid hormone and cortisol on prostaglandin production by neonatal rat calvaria in vitro.

  1985cited by this paper
• Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism.

  1982cited by this paper
• Prostaglandins: stimulation of bone resorption in tissue culture.

  1970cited by this paper
• Research Paper Mediators of Inflammation, 7, 195–199 (1998)

  year unknowncited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with

  year unknowncited by this paper
• Printed in U.S.A. Copyright © 1997 by The Endocrine Society Transcriptional Induction of Cyclooxygenase-2 in Osteoblasts Is Involved in Interleukin-6-Induced

  year unknowncited by this paper

• COX-2 inhibition as a therapeutic strategy for bone loss in Staphylococcus aureus osteomyelitis

  2025cites this paper
• Advances in therapeutic applications of fish oil: A review

  2024cites this paper
• Effect of direct oral anticoagulant dabigatran on early bone healing: An experimental study in rats

  2023cites this paper
• Crosstalk between the neuroendocrine system and bone homeostasis.

  2023cites this paper
• Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies

  2021cites this paper
• Etoricoxib decreases subchondral bone mass and attenuates biomechanical properties at the early stage of osteoarthritis in a mouse model.

  2020cites this paper
• Prostaglandins and bone metabolism

  2020cites this paper
• Emerging Therapies in Periodontics

  2020cites this paper
• Omega-3 fatty acid-rich sh oil supplementation prevents rosiglitazone-induced osteopenia in insulin resistant c57bl/6 mice and in vitro studies

  2020cites this paper
• Role of Interleukins on Physiological and Pathological Bone Resorption and Bone Formation: Effects by Cytokines in The IL-1 and IL-2 Families

  2020cites this paper
• Salicylic Acid Polymers in Periodontal Tissue Healing

  2020cites this paper
• Bone Benefits of Fish Oil Supplementation Depend on its EPA and DHA Content

  2019cites this paper
• Prostaglandins and Bone.

  2019cites this paper
• Teriparatide (human PTH1-34) compensates for impaired fracture healing in COX-2 deficient mice.

  2018cites this paper
• The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice

  2017cites this paper
• The protective effect of berberine hydrochloride on LPS‑induced osteoclastogenesis through inhibiting TRAF6‑Ca2+‑calcineurin‑NFATcl signaling pathway.

  2017cites this paper
• Local targeting of anabolic drug conjugates for treatment of bone loss after tooth extraction

  2017cites this paper
• Selective COX-2 Inhibitor (Meloxicam) and Tooth-Supporting Bone Quality. A Histomorphometric Study in Rats.

  2017cites this paper
• Regulatory Mechanisms of Bone Development and Function

  2016cites this paper
• Controlled and sustained polymeric drug delivery systems for diabetic bone healing

  2016cites this paper
• Nonsteroidal Anti-Inflammatory Drugs Cause Inhibition of the Growth Plate in Cultured Rat Metatarsal Bones: Retracted.

  2016cites this paper
• Lupeol acetate ameliorates collagen-induced arthritis and osteoclastogenesis of mice through improvement of microenvironment.

  2016cites this paper
• Role of Epithelium Sodium Channel in Bone Formation

  2016cites this paper
• Bone Physiology: Bone Cells, Modeling, and Remodeling

  2015cites this paper
• Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells

  2015cites this paper
• Cyclooxygenase-2 Suppresses the Anabolic Response to PTH Infusion in Mice

  2015cites this paper
• Continuous PTH: A Tale of Two Pathways

  2015cites this paper
• The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation.

  2014cites this paper
• November 2014 PeriOperative Use of Injectable Rimadyl ® ( carprofen )

  2014cites this paper
• Investigating In Vivo Efficacy of Novel ALN-EP4a Conjugate Drugs for the Treatment of Post-menopausal Osteoporosis

  2014cites this paper
• Celecoxib, a selective cyclooxygenase‐2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis

  2014cites this paper
• Effect of dietary supplementation with conjugated linoleic acid on bone mineral density, bone metabolism markers and inflammatory markers in healthy post-menopausal women: a randomized double blind placebo controlled trial

  2014cites this paper
• Immunohistochemical Localization of Key Arachidonic Acid Metabolism Enzymes during Fracture Healing in Mice

  2014cites this paper
• Interleukin-1 Receptor-associated Kinase-4 (IRAK4) Promotes Inflammatory Osteolysis by Activating Osteoclasts and Inhibiting Formation of Foreign Body Giant Cells*

  2014cites this paper
• The protocol for the isolation and cryopreservation of osteoclast precursors from mouse bone marrow and spleen

  2014cites this paper
• TDAG8 activation inhibits osteoclastic bone resorption

  2014influential citation
• Conjugated Linoleic Acid Prevents Ovariectomy-Induced Bone Loss in Mice by Modulating Both Osteoclastogenesis and Osteoblastogenesis

  2014cites this paper
• the enthesis NSAID therapy effects on healing of bone, tendon, and

  2013cites this paper
• NSAID therapy effects on healing of bone, tendon, and the enthesis.

  2013cites this paper
• IL‐4 and IL‐13 inhibit IL‐1β and TNF‐α induced kinin B1 and B2 receptors through a STAT6‐dependent mechanism

  2013cites this paper
• Locally delivered salicylic acid from a poly(anhydride-ester): impact on diabetic bone regeneration.

  2013cites this paper
• Selective and Non-Selective Cyclooxygenase Inhibitors Delay Stress Fracture Healing in the Rat Ulna

  2013cites this paper
• Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro

  2013cites this paper
• Pharmacologic Interventions with NSAIDs

  2013cites this paper
• Gallotannin causes differentiation and inflammation via ERK‑1/‑2 and p38 kinase pathways in rabbit articular chondrocytes.

  2013cites this paper
• Thrombin inhibits osteoclast differentiation through a non-proteolytic mechanism.

  2013cites this paper
• Selective and non‐selective cyclooxygenase inhibitors delay stress fracture healing in the rat ulna

  2013cites this paper
• Case Studies in Electrolyte and Acid–Base Disorders

  2013cites this paper
• Ovarian cancer G-protein-coupled receptor 1 induces the expression of the pain mediator prostaglandin E2 in response to an acidic extracellular environment in human osteoblast-like cells.

  2012cites this paper
• Bone–Tendon–Ligament System

  2012cites this paper
• Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1β in osteoarthritic osteoblasts.

  2012cites this paper
• Hydrogen sulphide‐releasing diclofenac derivatives inhibit breast cancer‐induced osteoclastogenesis in vitro and prevent osteolysis ex vivo

  2012cites this paper
• Effects of cox inhibitors on bone and tendon healing

  2011cites this paper
• Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor.

  2011cites this paper
• Nobiletin, a polymethoxy flavonoid, suppresses bone resorption by inhibiting NFκB-dependent prostaglandin E synthesis in osteoblasts and prevents bone loss due to estrogen deficiency.

  2011cites this paper
• Phosphatidylserine-Containing Liposomes: Potential Pharmacological Interventions Against Inflammatory and Immune Diseases Through the Production of Prostaglandin E2 After Uptake by Myeloid Derived Phagocytes

  2011cites this paper
• IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.

  2011cites this paper
• Protective effects of COX-2 inhibitor on titanium-particle-induced inflammatory osteolysis via the down-regulation of RANK/RANKL.

  2011cites this paper
• Up-Regulation of the Inflammatory Response by Ovariectomy in Collagen-Induced Arthritis. Effects of Tin Protoporphyrin IX

  2011cites this paper
• Heme oxygenase-1 mediates protective effects on inflammatory , catabolic and senescence responses induced by interleukin-1 b in osteoarthritic osteoblasts

  2011cites this paper
• Reciprocal cross-talk between Prostaglandin E2 and bone in prostate cancer: a current review

  2011cites this paper
• Glucocorticoid-Induced Osteoporosis: Basic Pathological Mechanisms, Clinical Features, and Management in the New Millennium

  2011cites this paper
• Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells.

  2010cites this paper
• Bone resorptive activity of osteoclast-like cells generated in vitro by PEG-induced macrophage fusion.

  2010cites this paper
• Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.

  2010cites this paper
• Basic Aspects of PTH in Skeletal Health

  2010cites this paper
• The Effects of COX-2 Inhibitor During Osteogenic Differentiation of Bone Marrow-Derived Human Mesenchymal Stem Cells

  2010cites this paper
• Phosphatidylserine-Containing Liposomes Inhibit the Differentiation of Osteoclasts and Trabecular Bone Loss

  2010cites this paper
• Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function

  2010cites this paper
• PDE4 inhibitor upregulates PTH‐induced osteoclast formation via CRE‐mediated COX‐2 expression in osteoblasts

  2010cites this paper
• Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism

  2010cites this paper
• Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence.

  2009cites this paper
• Parecoxib and Indomethacin Delay Early Fracture Healing: A Study in Rats

  2009cites this paper
• Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures.

  2009cites this paper
• Pathophysiology of Cyclooxygenase Inhibition in Animal Models

  2009cites this paper
• Regulation of the prostaglandin pathway during development of invasive bladder cancer in mice.

  2009cites this paper
• Efficacy of Newly Synthesized Melatonin Derivatives as Antiosteoporotic Agents in Ovariectomized Rats.

  2009cites this paper
• A distinctive role of the leukotriene B4 receptor BLT1 in osteoclastic activity during bone loss

  2009influential citation
• Osteoclast Precursors: Regulation by Prostaglandins.

  2009influential citation
• ProstaglandinEP2andEP4 receptoragonistsinbone formationandbonehealing: In vivoandin vitroevidence

  2009cites this paper
• Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence

  2009cites this paper
• Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats

  2008cites this paper
• Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders.

  2008cites this paper
• The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease.

  2008cites this paper
• Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice.

  2008cites this paper
• Effect of meloxicam and diclofenac sodium on peri-implant bone healing in rats.

  2008cites this paper
• Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.

  2008cites this paper
• Celecoxib, NSAIDs and the skeleton.

  2008cites this paper
• Negative effect of parecoxib on bone mineral during fracture healing in rats

  2008cites this paper
• Take two aspirin: for osteoporosis?

  2008cites this paper
• Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A 2 (iPLA 2 (cid:1) )-Null Mice

  2008cites this paper
• Ectopic expression of cyclooxygenase-2-induced dedifferentiation in articular chondrocytes

  2008cites this paper
• Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.

  2008cites this paper
• Introduction to Bone Development, Remodelling and Repair

  2008cites this paper
• Cyclooxygenase‐2 Expression and Prostaglandin E2 Production in Response to Acidic pH Through OGR1 in a Human Osteoblastic Cell Line

  2008cites this paper
• Celecoxib prevents juxta-articular osteopenia and growth plate destruction adjacent to inflamed joints in rats with collagen-induced arthritis

  2007cites this paper
• Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing.

  2007cites this paper
• Administration of Cyclooxygenase-2 Inhibitor Reduces Joint Inflammation but Exacerbates Osteopenia in IL-1α Transgenic Mice Due to GM-CSF Overproduction

  2007cites this paper
• Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.

  2007cites this paper
• Adverse Effects of Sustained Morphine Treatment in an Experimental Model of Bone Cancer Pain: Mechanisms That Underlie Hyperalgesia and Osteoclastogenesis

  2007cites this paper